• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SOFRADIM PRODUCTION SAS UGYTEX; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR PELVIC ORGAN PROLAPSE, TRANSVAGIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SOFRADIM PRODUCTION SAS UGYTEX; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR PELVIC ORGAN PROLAPSE, TRANSVAGIN Back to Search Results
Model Number UGYKP
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Incontinence (1928); Pain (1994); Urinary Tract Infection (2120); Urinary Frequency (2275); Injury (2348); Ascites (2596); Blood Loss (2597); Foreign Body In Patient (2687); No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
This event was previously reported to the fda on an alternative summary report (asr approval #: e2013038) which is no longer in effect.Because of additionally received complaint information, this and all further updates will be submitted through the 3500a form.Concomitant medical products: system t-sling with centrasorb¿.If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of stress incontinence, symptomatic cystocele and rectocele.It was reported that after implant, the patient experienced post-op blood loss requiring transfusion of two units of blood, small area of heterogenous fluid collection in left sidewall, foreign body in the genitourinary tract, pelvic pain, dyspareunia, urge incontinence, urinary frequency, frequent urinary tract infections, urinary stream abnormality, stress incontinence.Post-operative patient treatment included surgical intervention.The device had been used with avaulta¿ anterior biosynthetic support system t-sling with centrasorb¿.
 
Manufacturer Narrative
Correction: (outcome attributed to adverse event change to intervention required).If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UGYTEX
Type of Device
MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR PELVIC ORGAN PROLAPSE, TRANSVAGIN
Manufacturer (Section D)
SOFRADIM PRODUCTION SAS
116 avenue du formans
trevoux 01600
FR  01600
MDR Report Key9251227
MDR Text Key164166015
Report Number9615742-2019-03554
Device Sequence Number1
Product Code OTP
Combination Product (y/n)N
PMA/PMN Number
K051503
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Type of Report Initial,Followup
Report Date 11/06/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/29/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/30/2011
Device Model NumberUGYKP
Device Catalogue NumberUGYKP
Device Lot NumberZGJ00133
Was Device Available for Evaluation? No
Date Manufacturer Received10/30/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
AVAULTA¿ ANTERIOR BIOSYNTHETIC SUPPORT; AVAULTA¿ ANTERIOR BIOSYNTHETIC SUPPORT
Patient Outcome(s) Other; Required Intervention;
Patient Age52 YR
-
-